Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Burr Warns User Fee Renewal Could Be Difficult Without Performance Measure Improvements

Jul 28 2011

• By The Pink Sheet Daily

Related Content

The REMS Filibuster: FDA Wants Ability To End Post-Approval Talks, Make Final Decision

Dec 20 2010

How "Clean" Will PDFUA V Be? Rep. Pitts Explains His Vacuuming Technique

Jul 18 2011

Not Another FDAAA – Observers Expect Fewer FDA Reforms In PDUFA V

Jul 11 2011

What’s In A PDUFA Reauthorization? Maybe These Issues…

Jul 11 2011

PDUFA Proposal Sheds Tier 3 Funding

May 02 2011

Pre-NDA Work Takes Added Importance As PDUFA V Stretches Review Cycle

May 09 2011

Sens. Burr and Coburn Want User Fee Bills That Streamline Regulation

Jun 20 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window